萬達電影(002739.SZ):輕資產影院票房收入不計入公司票房收入
格隆匯7月28日丨有投資者向萬達電影(002739.SZ)提問,“請問:1、萬達電影2023年6月30號披露的16.8%市佔率是否包括輕資產項目?2、輕資產項目的市佔率為多少?輕資產項目票房是否計入萬達電影,輕資產項目收入在財報中如何體現?3、自有影院票房及市佔率為多少?可以通過何種渠道查詢萬達自有影院票房及市佔率?”
萬達電影回覆稱,公司披露的市佔率包括輕資產影院,2023年1-6月,公司直營影院市場份額15.4%,輕資產市場份額約1.4%,您可以通過貓眼專業版等第三方平台查詢。輕資產影院票房收入不計入公司票房收入,公司收取的相關影院委託管理費、品牌使用費等收入計入公司其他業務收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.